Routine symptom screening identifies substantial supportive care needs before radiotherapy
Among 1,251 patients, 67% receiving curative and 80% receiving palliative radiotherapy reported at least one high-burden concern.
Among 1,251 patients, 67% receiving curative and 80% receiving palliative radiotherapy reported at least one high-burden concern.
Among 39 palliative bone radiotherapy studies, 33% omitted the pain metric and 51% omitted the recall period.
In 280 patients receiving palliative thoracic RT, CT-detected airway obstruction was associated with 2.6-fold higher adjusted odds of clinical airway events.
A 33 Gy/6-fraction boost regimen improved plexus-related symptoms in 84% of evaluable patients and achieved 74% freedom from local progression at one year.
Pain response after reirradiation was 60% in lesions that previously responded to RT versus 15% after primary nonresponse.
Diagnostic CT-based VMAT preserved PTV D95 at 99.6% of planned dose across 30 palliative bone RT plans.
A routine departmental workflow delivered rapid palliative RT with a median 109-minute treatment process despite having no dedicated rapid-access clinic.
Compared with 8 Gy in one fraction, five- and ten-fraction regimens were associated with approximately two- and threefold higher odds of lymphopenia.
An integrated CT-linac workflow delivered emergency radiotherapy in 24.7 minutes, with symptom relief in nearly 90% of patients.
Three Quad Shot cycles caused limited high-grade toxicity, no systemic-therapy delays and frequent thoracic symptom improvement.
Across six randomized studies, prophylactic corticosteroids reduced radiation-induced pain-flare risk by 37%, although regimens and safety reporting varied.
In 232 women with breast cancer leptomeningeal disease, radiotherapy was not associated with longer overall survival, while systemic therapy was.
The OSCAR workflow delivered the first urgent or palliative fraction without planning CT in approximately 1 hour 50 minutes.
COMPPARE enrolled 2,524 patients from 51 institutions in 52 months, with Black participation reaching 16% of the cohort.
Pain should remain central for symptomatic disease, but prevention, function, local control and skeletal events require separate standardized endpoints.